Funds and ETFs Mayne Pharma Group Limited

Equities

MYX

AU000000MYX0

Pharmaceuticals

Market Closed - Australian S.E. 07:10:36 15/05/2024 BST 5-day change 1st Jan Change
6.1 AUD -8.41% Intraday chart for Mayne Pharma Group Limited -16.09% -0.81%
Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.1 AUD
Average target price
7.035 AUD
Spread / Average Target
+15.33%
Consensus
  1. Stock Market
  2. Equities
  3. MYX Stock
  4. Funds and ETFs Mayne Pharma Group Limited